User:George L Gabor Miklos
The account of this former contributor was not re-activated after the server upgrade of March 2022.
George L Gabor Miklos BSc PhD is an international private advisor to institutions and individuals in the areas of molecular clinical information and advanced molecular technologies. He is Director of Secure Genetics Pty Limited a private biomedical consulting company. He holds a Bachelors degree in mathematics and zoology and a PhD in Genetics from the University of Sydney (1970). He has been an advisor to CELERA on the Human, Mouse and Drosophila Genome Projects, to NOVARTIS Pharmaceuticals in functional genomics and to different biotechnology companies in the areas of cervical cancer, microbial detection systems, DNA methylation, adult stem cells, pharmacogenomics of cardiovascular disease, Alzheimers disease and advanced diagnostic technologies such as Multi Photon Detection. He has been a reviewer of programs in the American Museum of Natural History and the New York Botanical Gardens.
His publications are in a broad spectrum of scientific disciplines, from his 1988 book, The Eukaryote Genome in Development and Evolution, (with Bernard John); The Role of the Genome Project (with Gerry Rubin); the first genetic dissection of a eukaryote genome by segmental aneuploidy at the University of California, San Diego; the first complementation analysis of mitochondrial genomes in yeast; microarray analyses of schizophrenia; relaxation complexes in bacteria; genomic evolution and paleontological aspects of development in different phyla; molecules and cognition; the emergence of complexity in nervous systems and The Human Cancer Genome Project. He has been an invited speaker at diverse symposia such at the Nobel Symposium on Early Life on Earth; Mathematical Analysis and its applications in Economics, Evolutionary Theory and Bioinformatics; and the Evolution and modification of brains and sensory systems.
In a former life he held a Fulbright Scholarship, academic and visiting positions at the Australian National University, the University of Edinburgh, Scotland, the University of Washington, Seattle, the Neurosciences Institute, California and the Scripps Institute, La Jolla, California. He was secretary of the Genetics Society of Australia and has appeared before members of the Australian Senate on the topic of Recombinant DNA. In the corporate sphere he was Vice President and Chief Scientific Officer for Human Genetic Signatures Pty Ltd. His current interests are in the War on Cancer, diagnostic nanotechnologies for early cancer detection, drug-induced molecular alterations in human stem cells, amelioration of human diseases via cellular therapeutics, attractor basins of different human cell types during disease, and evaluation of genetic background in network contexts. He holds no shares in Pharmaceutical, Biotechnological or Healthcare companies nor receives any payments from governmental sources and declares no conflicts of interest. He lives on the Northern beaches of Sydney, Australia.
Web site: http://www.securegenetics.com
Publications: http://www.securegenetics.com/publications.html
Contact: [email protected]
Specializations
...specify as list